Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IV ketamine plus standard treatment versus standard treatment for migraine in the emergency department
IRCT20170224032753N2Phase 3Completed
- Sponsor
- Hormozgan University of Medical Sciences
- Start
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of ketamine, ketorolac and metoclopramide in migraine (2 arms), sponsored by Hormozgan University of Medical Sciences. Primary endpoint: Headache intensity. Started Oct 2019; status: completed.
02
Drugs
ketamineketorolacmetoclopramide
03
Conditions
migraine
Beyond the preview
Go deeper on IRCT20170224032753N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20170224032753N2.